메뉴 건너뛰기




Volumn 69, Issue 8, 2004, Pages 1983-1984

Teriparatide (Forteo) for Osteoporosis

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCITONIN; CALCIUM; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; VITAMIN D;

EID: 1942437385     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey
Times cited : (4)

References (3)
  • 1
    • 0037527036 scopus 로고    scopus 로고
    • Forteo (teriparatide) by Eli Lilly and Company
    • Forteo package insert. 2002. Forteo (teriparatide) by Eli Lilly and Company. Accessed online March 10, 2004, at: http://pi.lilly.com/us/forteo-pi.pdf.
    • (2002) Forteo Package Insert
  • 2
    • 0035837553 scopus 로고    scopus 로고
    • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
    • Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
    • (2001) N Engl J Med , vol.344 , pp. 1434-1441
    • Neer, R.M.1    Arnaud, C.D.2    Zanchetta, J.R.3    Prince, R.4    Gaich, G.A.5    Reginster, J.Y.6
  • 3
    • 0344269895 scopus 로고    scopus 로고
    • Montvale, NJ: Medical Economics Data
    • 2003 Drug topics. Red Book. Montvale, NJ: Medical Economics Data, 2003.
    • (2003) 2003 Drug Topics. Red Book


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.